In the retina, rod cells handle dim light and cone cells handle daylight and colour — and ‘rod-cone dystrophy’ simply describes which set fails first. Here, it’s the rods, with cone involvement following only later, and that sequence is exactly what places most classic retinitis pigmentosa cases under this label. It matters clinically because it predicts, fairly reliably, which visual functions will fade first and which will hold on the longest.
For a patient from Kenya who arrives with this specific term already written on a referral letter, understanding that rod-first order clears up a lot from the very first conversation — rather than leaving them to guess at what the label actually means for their day-to-day vision.
10+
years Experience
years Experience
5000+
Patients treated
Patients treated
100+
Countries served
Countries served
NABH
Guided facility
Guided facility
Ocular Symptoms
Since the rods go first, difficulty with night vision and a narrowing field of view tend to dominate the early and middle stages, while central vision and colour perception generally hold steady during that same period — only declining later, once the cones become involved too. Patients often describe the change less as blurriness and more as their surroundings gradually closing in from the sides.
Underlying Causes
The rod-first sequence traces back to mutations in genes that matter more heavily to rod survival specifically, which explains much of the genetic overlap between this pattern and the broader RP landscape. Inheritance can be dominant, recessive, or X-linked depending on which gene is at fault, and the condition can appear on its own or as one feature within a wider syndrome affecting other organs.
Diagnosis for Kenyan Patients
Electroretinography does most of the work in separating rod-cone dystrophy from its mirror image, cone-rod dystrophy: here, the rod-driven response comes back disproportionately reduced compared with the cone-driven response, especially early on. Visual field testing maps how far the peripheral loss extends, and OCT shows how intact the remaining photoreceptor layers still are.
Meet The Team
Our Eye Specialists
Dr. Pawan
Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience
Retinal disorders, diabetic retinopathy, and advanced retina procedures. Provides diagnostic evaluation and treatment planning for international patients.
Dr.Pallavee
Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience
Areas of Focus: Cataract surgery, corneal disorders, refractive procedures, and glaucoma management. Provides comprehensive eye care and surgical expertise for global patients.
Dr. Robin
Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Areas of Focus: Cataract surgery, corneal disorders, refractive procedures, and glaucoma management. Provides comprehensive eye care and surgical expertise for global patients.
Treatment Approach in India
Care follows the same regenerative and supportive approach used across the progressive dystrophies — stem cell therapy gets weighed up for patients whose test results suggest they’re reasonable candidates, alongside practical guidance for adjusting to reduced night and peripheral vision while central vision holds comparatively stable for a longer stretch.
Reviews
What Our Patients Say
DR NAAGALAKSHMI R
1 week ago
Asha Babbar
2 weeks ago
The overall experience at the RP Treatment Center was very good. The staff was supportive and caring, and we provided proper attention and guidance during treatment. The environment at the center was clean and comfortable. The doctors and staff tried to understand patients' needs and explained the treatment process well.
Overall, I am satisfied with the service and care. Highly recommended!
Overall, I am satisfied with the service and care. Highly recommended!
Harshita Kapoor
2 weeks ago
Life‑Changing Experience with RP Therapy”
After years of struggling with vision loss due to Retinitis Pigmentosa, I finally found hope here. The doctors were highly professional, explained the stem cell treatment in detail, and gave me confidence at every step. The therapy was smooth, and I’ve already noticed positive changes in my daily life. Their dedication, care, and advanced medical approach make this center truly trustworthy
After years of struggling with vision loss due to Retinitis Pigmentosa, I finally found hope here. The doctors were highly professional, explained the stem cell treatment in detail, and gave me confidence at every step. The therapy was smooth, and I’ve already noticed positive changes in my daily life. Their dedication, care, and advanced medical approach make this center truly trustworthy
Yash Chauhan
2 weeks ago
I had a really good experience at RP Treatment Centre. The doctor listened to my problem patiently and explained the treatment in a simple way. The staff was polite and the clinic was clean. I started feeling better after the treatment. Highly recommended!
pragya chauhan
2 weeks ago
Very satisfied with the service. The doctor is experienced and gives proper attention to every patient. The staff is friendly, and the overall environment is comfortable. Thank you, RP Treatment Centre, for the excellent care.
Manisha kapoor
2 weeks ago
I had been struggling with Retinitis Pigmentosa for years, and finding this center was truly life‑changing. The doctors provided a thorough medical evaluation and explained every step of the stem cell therapy process with clarity. The treatment was smooth, professional, and I noticed encouraging improvements in my vision within weeks. Their continuous follow‑up care and compassionate support made me feel confident throughout the journey. Highly recommended for anyone seeking advanced RP treatment in India.
Frequently Asked Questions
Is rod-cone dystrophy really just another way of saying RP?
“There’s substantial overlap between the two terms. ‘Rod-cone dystrophy’ names the order the disease follows — rods first, cones later — and that specific order applies to most of what gets clinically labelled retinitis pigmentosa.”
What actually separates rod-cone from cone-rod dystrophy?
”
It comes down to which type of cell fails first. Rod-cone dystrophy hits night and peripheral vision early while central and colour vision hold up longer; cone-rod dystrophy runs the reverse, with central and colour vision affected sooner.”
Is my central vision going to be next?
“In many rod-cone cases, eventually yes — central vision can decline once the disease has progressed far enough to reach the cones, though the timeline for that varies considerably from one gene, and one patient, to the next.”
How often will I need to come back for monitoring?
“That gets decided case by case, based on how quickly your ERG and field results are shifting after the first evaluation. Some patients need only annual review, while others with a faster-moving pattern are seen more frequently.”
